Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

Miyares MA, Davis K

Vascular Health and Risk Management 2012, 8:483-493

Published Date: 23 August 2012